2005年

  1. Zhuge X, Kataoka H, Tanaka M, Murayama T, Kawamoto T, Sano H, Togi K, Yamauchi R, Xu Y, Nishikawa S-I, Kita T, Ueda Y, Yokode M: Expression of Smuc, a Novel Snail-related Zinc Finger Transcription Factor, During Pre and Postnatal Mouse Development. Int J Mol Med. 15(6): 945-948, 2005
  2. Takahashi T, Abe H, Arai, H, Matsubara T, Nagai K, Matsuura M, Iehara N, Yokode M, Nishikawa S, Kita T, Doi T: Activation of STAT3/Smad1 is a key signaling pathway for progression to glomerulosclerosis in experimental glomerulonephritis. J Biol Chem 280:7100-7106, 2005.
  3. Nagai K, Matsubara T, Mima A, Sumi E, Kanamori H, Iehara N, Fukatsu A, Yanagita M, Nakano T, Ishimoto Y, Kita T, Doi T, Arai H: Gas6 induces Akt/mTOR-mediated mesangial hypertrophy in diabetic nephropathy. Kidney Int..68(2): 552-561,2005
  4. Zhuge X, Murayama T, Arai H, Yamauchi R, Tanaka M, Shimaoka T, Yonehara S, Kume N, Yokode M, Kita T:CXCL16 is a novel angiogenic factor for human umbilical vein endothelial cells. Biochem. Biophys. Res. Commun. 331(4):1295-1300, 2005
  5. Tanaka M, Arai H, Liu N,Nogaki F, Nomura K, Kasuno K, Oida E, Kita T, Ono T: Role of coagulation factor Xa and protease-activated receptor 2 in human mesangial cell proliferation. Kidney Int..67(6):2123-2133,2005
  6. Arai H, Yamamoto A, Matsuzawa Y, Saito Y, Yamada N, Oikawa S, Mabuchi H,Teramoto T, Sasaki J, Nakaya N, Itakura H, Ishikawa Y, Ouchi Y, Horibe H, Kita T :Serum Lipid Survey and its.Recent Trend in the General Japanese Population in 2000. J Arteriosclerosis Thrombosis.12(2):98-106,2005
  7. Arai H, Yamamoto A, Matsuzawa Y, Saito Y, Yamada N, Oikawa S, Mabuchi H, Teramoto T, Sasaki J, Nakaya N, Itakura H, Ishikawa Y, Ouchi Y, Horibe H, Egashira T,Hattori H, Shirahashi N, Kita T : Polymorphisms in Four Genes Related to Triglyceride and HDL-cholesterol Levels in the General Japanese Population in 2000. J Atheroscler Thromb.12(5)240-250,2005
  8. Wada T, Ishine M, Sakagami T, Kita T, Okumiya, K, Mizuno K, TA Rambo, Matsubayashi K: Depression, activities of daily living, and quality of community-dwelling Elderly in three Asian countries: Indonesia, Vietnam, and Japan. Arch Gerontol Geriatr.41(3):271-280,2005
  9. Furukawa Y, Tamura T, Toma M, Abe M, Saito N, Ehara N, Taniguchi R, Nakagawa Y, Kita T, Kimura T: Sirolimus-Eluting Stent for In-Stent Restenosis of Left Main Coronary Artery in Takayasu Arteritis. Circ J. 69: 752-755, 2005
  10. Tadamura E, Yamamuro M, Kubo S, Kanao S, Saga T, Harada M, Ohba M, Hosokawa R, Kimura T, Kita T, Togashi K.: Effectiveness of delayed enhanced MRI for identification of cardiac sarcoidosis: comparison with radionuclide imaging. Am J Roentgenol. Jul;185(1):110-115.2005
  11. Mamede M, Tadamura E, Hosokawa R, Ohba M, Kubo S, Yamamuro M, Kimura T, Kita T, Saga T, Togashi K.: Comparison of myocardial blood flow induced by adenosine triphosphate and dipyridamole in patients with coronary artery Disease. Ann Nucl Med. Dec;19(8):711-7,2005
  12. Hayashida K, Kume N, Murase T, Minami M, Nakagawa D, Inada T, Tanaka M, Ueda A, Kominami G, Kambara H, Kimura T, Kita T.: Serum soluble lectin-like oxidized low-density lipoprotein receptor-1 levels are elevated in acute coronary syndrome: a novel marker for early diagnosis.:Circulation: Aug 9;112(6):812-8,2005
  13. Hosokawa R, Nohara R, Hirai T, Fujibayashi Y, Fujita M, Kambara N, Ohba M, Tadamura E, Kimura T, Kita T: Myocardial metabolism of 123I-BMIPP under low-dose dobutamine infusion: implications for clinical SPECT imaging of ischemic heart disease. Eur J Nucl Med Mol I 32(1): 75-83, 2005.
  14. Kanao S, Tadamura E, Yamamuro M, Kubo S, Kimura T, Kita T, Togashi K.:Demonstration of cardiac involvement of sarcoidosis by contrast-enhanced multislice computed tomography and delayed-enhanced magnetic resonance imaging.: J Comput Assist Tomogr.:Nov-Dec;29(6):745-8,2005
  15. Yamamuro M, Tadamura E, Kubo S, Toyoda H, Nishina T, Ohba M, Hosokawa R, Kimura T, Tamaki N, Komeda M, Kita T, Konishi J.:Cardiac functional analysis with multi-detector row CT and segmental reconstruction algorithm: comparison with echocardiography, SPECT, and MR imaging.:Radiology. :Feb;234(2):381-90,2005
  16. Shirakawa R, Higashi T, Kondo H, Yoshioka A, Kita T, Horiuchi H: Purification and functional analysis of a Rab27 effector Munc13-4 using a semi-intact platelet dense-granule secretion assay. Methods Enzymol. 403, 778-788, 2005
  17. Makiyama T, Akao M, Tsuji K, Doi T, Ohno S, Takenaka K, Kobori A, Ninomiya T, Yoshida H, Takano M, Makita N, Yanagisawa F, Higashi Y, Takeyama Y, Kita T, Horie M:High risk for bradyarrhythmic complications in patients with Brugada syndrome caused by SCN5A gene mutations. J Am Coll Cardiol. 46(11): 2100-2106, 2005
  18. Nogaki F, Oida E, Kamata T, Kobayashi I, Nomura K, Suyama K, Tahara S, Ono T, Miyawaki S, Serikawa T, Yoshida H, Kita T, Muso E:Chromosomal mapping of hyperserum IgA and glomerular IgA deposition in a high IgA (HIGA) strain of DdY mice.Kidney Int. 68(6):2517-2525, 2005
  19. Okabe T, Kishimoto C, Shimada K, Murayama T, Yokode M, Kita T:Effects of late administration of immunoglobulin on experimental atherosclerosis in apolipoprotein E-deficient mice. Circ J.69(12): 1543- 1546, 2005
  20. Shimamoto K, Kita T, Mabuchi H, Matsuzaki M, Matsuzawa Y, Nakaya N, Oikawa S, Saito Y, Sasaki J, Itakura H; J-LIT Study Group :The risk of cardiovascular events in japanese hypertensive patients with hypercholesterolemia: sub-analysis of the Japan Lipid Intervention Trial (J-LIT) Study, a large-scale observational cohort study. Hypertens Res.(11):879-887, 2005
  21. Tadamura E, Yamamuro M, Kubo S, Kanao S, Saga T, Harada M, Ohba M, Hosokawa R, Kimura T, Kita T, Togashi K. : Effectiveness of delayed enhanced MRI for identification of cardiac sarcoidosis: comparison with radionuclide imaging.:Am J Roentgenol.185(1):110-115, 2005
  22. Nomura I, Kato N, Kita T, Takechi H:Mechanism of impairment of long-term potentiation by amyloid beta is independent of NMDA receptors or voltage-dependent calcium channels in hippocampal CA1 pyramidal neurons. Neurosci Lett. 391(1-2): 1-6, 2005
  23. Kanao S, Tadamura E, Yamamuro M, Kubo S, Kimura T, Kita T, Togashi K:Demonstration of cardiac involvement of sarcoidosis by contrast-enhanced multislice computed tomography and delayed-enhanced magnetic resonance imaging.J Comput Assist Tomogr. 29(6): 745-748, 2005
  24. Saito N, Kimura T, Odashiro K, Toma M, Nobuyoshi M, Ueno K, Kita T, Inoue K:Feasibility of the Inoue single-branched stent-graft implantation for thoracic aortic aneurysm or dissection involving the left subclavian artery: short- to medium-term results in 17 patients. J Vasc Surg. 41(2):206-212, 2005
  25. Matsumori A: Hepatitis C virus infection and cardiomyopathies. Circ Res 96(2): 144-147, 2005
  26. Matsumori A: Emerging treatments for viral myocarditis. Future Cardiol. 1(5): 683-692, 2005.
  27. Shichi D, Kikkawa EF, Ota M, Katsuyama Y, Kimura A, Matsumori A, Kulski JK, Naruse TK, Inoko H.: The haplotype block, NF?B-ATP6VG2-BAT1-MLCA, within the class III- class I boundary region of the human major histocompatibility complex may control susceptibility to hepatitis C virus-associated dilated cardiomyopathy. Tissue Antigens 66: 200-208, 2005.
  28. Kinoshita M, Okada M, Hara M, Furukawa Y, Matsumori A.: Mast cell tryptase in mast cell granules enhances MCP-1 and Interleukin-8 production in human endothelial cells. Arterioscler Thromb Vasc Biol. 25: 1858-1863, 2005
  29. Nishiyama K: Coronary stenting improves myocardial salvage more than angioplasty when thrombolysis fails in acute myocardial infarction (Commentary). Evid Based Cardiovasc Med. 2005 Mar;9(1):64-5.
  30. Saito, N., Kimura, T., Toma, M. et al. Transcatheter closure of patent ductus arteriosus with the Inoue single-branched stent graft. J Thorac Cardiovasc Surg 130, 1203-4, 2005
  31. Yamada T, Inoue K, Hamasaki N, Nakagawa Y, Iwabuchi M, Yokoi H, Kimura T, Nosaka H, Nobuyoshi M.: Late restenosis of the balloon-dilated site: serial angiographic observations beyond 7 years.: Circ J. Apr;69(4):380-5,2005
  32. Kanao S, Tadamura E, Yamamuro M, Kubo S, Kimura T, Kita T, Togashi K.: Demonstration of cardiac involvement of sarcoidosis by contrast-enhanced multislice computed tomography and delayed-enhanced magnetic resonance imaging.: J Comput Assist Tomogr.: Nov-Dec;29(6):745-8,2005
  33. Yamamuro M, Tadamura E, Kubo S, Toyoda H, Nishina T, Ohba M, Hosokawa R, Kimura T, Tamaki N, Komeda M, Kita T, Konishi J.: Cardiac functional analysis with multi-detector row CT and segmental reconstruction algorithm: comparison with echocardiography, SPECT, and MR imaging.: Radiology. : Feb;234(2):381-90,2005
  34. Sawada H, Yamakawa K, Yamakado H, Hosokawa R, Ohba M, Miyamoto K, Kawamura T, Shimohama S: Cacaine and phenylephrine eye drop test for Parkinson disease. JAMA ?J Am Med Assoc 2005; 293: 932-934
  35. Yuan Z, Nimata M, Okabe T, Shioji K, Hasegawa K, Kita T, Kishimoto C : Olmesartan, a novel angiotensin II receptor type 1 antagonist, suppressed cytotoxic myocardial injury in autoimmune heart failure. Am J Physiol 289: H1147-H1152, 2005.
  36. Yuan Z, Liu Y, Liu Y, Zhang J, Kishimoto C, Wang Y, Ma A, Liu Z: Cardioprotective effects of PPAR-? activators in autoimmune myocarditis : anti-inflammatory actions associated with NF-??B blockade. Heart 91: 1203-1208, 2005.
  37. Nimata M, Okabe T, Hattori M, Yuan Z, Shioji K, Kishimoto C: MCI-186 (edaravone), a novel free radical scavenger, protect against acute autoimmune myocarditis in rats. Am J Physiol 289: H2514-H2518, 2005.
  38. Ohmae M, Kishimoto C, Tomioka N: Complete atrioventricular block in experimental murine myocarditis. J Electrocardiol 38, 230-234, 2005.
  39. Miwa K, Kishimoto C, Nakamura H, Makita T, Ishii K, Okuda N, Yodoi J, Sasayama S: Serum Thioredoxin and ?-tocopherol concentrations in patients with major risk factors. Circ J 69, 291-294, 2005.
  40. Kishimoto C, Hiraoka Y, Takada H, Kurokawa M, Ochiai H : Effects of immunoglobulin on murine myocarditis caused by influenza A virus : experimental study. J Cardiol 45, 247-255.
  41. Shinoda E, Yui Y, Kodama K, Hirayama A, Nonogi H, Haze K, Sumiyoshi T, Hosoda S, Kawai C: Quantitative coronary angiogram analysis, Nifedipine retard versus angiotensin-converting enzyme inhibitors (JMIC-B side arm study). Hypertension 45: 1153-1158, 2005
  42. Yamamoto K, Ishii E, Horiuchi H, Ueda I, Ohga S, Nishi M, Ogata Y, Zaitsu M, Morimoto A, Hara T, Imashuku S, Sasazuki T, Yasukawa M: Mutations of syntaxin 11 and SNAP23 genes as causes of familial hemophagocytic lymphohistiocytosis were not found in Japanese people. J. Hum. Genet. 50, 600-603.
  43. Ishii E, Ueda I, Shirakawa R, Yamamoto K, Horiuchi H, Ohga S, Furuno K, Morimoto A, Imayoshi M, Ogata Y, Sako M, Koike K, Sakata A, Takada H, Hara T, Imashuku S, Sasazuki T and Yasukawa M: Genetic subtypes of familial hemophagocytic lymphohistiocytosis: correlations with clinical features and cytotoxic T lymphocyte/natural killer cell functions. Blood 105: 3442-3448
  44. Shirakawa R, Higashi T, Kondo H, Yoshioka A, Kita T, Horiuchi H: Purification and functional analysis of a Rab27 effector Munc13-4 using a semi-intact platelet dense-granule secretion assay. Methods Enzymol. 403, 778-788
  45. Ha T, Li Y, Gao X, McMullen JR, Shioi T, Izumo S, Kelley JL, Zhao A, Haddad GE, Williams DL, Browder IW, Kao RL, Li C. Attenuation of cardiac hypertrophy by inhibiting both mTOR and NFkappaB activation in vivo. Free Radic Biol Med. 39: 1570-80; 2005.
  46. Maeda K, Shioi T, Kosugi R, Yoshida Y, Takahashi K, Machida Y, Izumi T. Rapamycin ameliorates experimental autoimmune myocarditis. Int Heart J. 46: 513-530; 2005.
  47. Iwanaga Y, Nishi I, Ono K, Takagi S, Tsutsumi Y, Ozaki M, Noguchi T, Takaki H, Iwai N, Nonogi H, Goto Y. Angiotensin-Converting Enzyme Genotype is not associated with Exercise Capacity or Training Effect of Cardiac Rehabilitation in Patients after Acute Myocardial Infarction. Circ J. 69: 1315-1319; 2005.
  48. Yokoi H, Makita N, Sasaki K, Takagi Y, Okumura Y, Nishino T, Makiyama T, Kitabatake A, Horie M, Watanabe I, Tsutsui H. : Double SCN5A mutation underlying asymptomatic Brugada syndrome. Heart Rhythm. 2(3):285-92.
  49. Hiraoka Y, Granja AT, Fialho AM, Achlarb-Ridley BG, Das Gupta TK, Chakrabarty AM, G2/M cell cycle arrest and induction of apoptosis. Biochem. Biophys. Res. Commun. 338: 1284-1290, 2005.
  50. Yanagita M: BMP antagonists: their roles in development and involvement in pathophysiology.Cytokine Growth Factor Rev. 16:309-17, 2005.
  51. Nagai K, Matsubara T, Mima A, Sumi E, Kanamori H. Iehara N, Fukatsu A, Yanagita M, Nakano T, Ishimoto Y, Kita T, Doi T & Arai H: Gas6 induces Akt/mTOR-mediated mesangial hypertrophy in diabetic nephropathy. Kidney Int. 68:552-61, 2005
  52. Kalaydjieva L, Lochmuller H, Tournev I, Baas F, Beres J, Colomer J, Guergueltcheva V, Herrmann R, Karcagi V, King R, Miyata T, Mullner-Eidenbock A, Okuda T, Milic Rasic V, Santos M, Talim B, Vilchez J, Walter M, Urtizberea A, Merlini L. 125th ENMC International Workshop: Neuromuscular Disorders in the Roma (Gypsy) Population, 23-25 April 2004, Naarden, The Netherlands. Neuromuscul Disord. 15: 65-71. 2005
  53. Kawamura T, Ono K, Morimoto T, Wada H, Hirai M, Hidaka K, Morisaki T, Heike T, Nakahata T, Kita T, Hasegawa K. Acetylation of GATA-4 is involved in the differentiation of embryonic stem cells into cardiac myocytes. J Biol Chem. 2005; 280(20):19682-8.
  54. Miwa K, Fujita M, Sasayama S: Recent insights into the mechanisms, predisposing factors, and racial differences of coronary vasospasm. Heart Vessels 20(1): 1-7, 2005.
  55. Fujita M, Tambara K, Ikemoto M, Sakamoto S, Ogai A, Kitakaze M, Sackner M: Periodic acceleration enhances release of nitric oxide in healthy adults. Int J Angiol 14:11-14, 2005.
  56. Mitani S, Fujita M, Shirakawa T: Circadian variation of cardiac autonomic nervous profile is affected in Japanese ambulancemen with a working system of 24-hour shifts. Int Arch Occ Env Hea 79(1): 27-32, 2005.

ページの先頭へ